HPV‐CCDC106 integration promotes cervical cancer progression by facilitating the high expression of CCDC106 after HPV E6 splicing. Issue 1 (28th July 2022)

• Record Type: Journal Article
• Authors: Zhi, Wenhua; Wei, Ye; Lazare, Cordelle; Meng, Yifan; Wu, Ping; Gao, Peipei; Lin, Shitong; Peng, Ting; Chu, Tian; Liu, Binghan; Ding, Wencheng; Cao, Canhui; Wu, Peng
• Is Part Of: Journal of medical virology. Volume 95:Issue 1(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-07-28
• Subjects: CCDC106 -- cervical cancer -- E6*I -- HPV integration; Virology -- Periodicals; 616
• DOI: 10.1002/jmv.28009
• Languages: English
• ISSNs: 0146-6615

Abstract

Abstract: Human papillomavirus (HPV) integration and high expression of HPV oncogenes ( E6 and E7 ) are important mechanisms for HPV carcinogenesis in cervical cancer. However, the relationship between HPV integration and HPV E6 spliced transcripts, as well as the underlying mechanisms of HPV integration in carcinogenesis after HPV E6 splicing remains unclear. We analyzed HPV‐coiled‐coil domain containing 106 ( CCDC106 ) integration samples to characterize the roles of HPV integration, E6 spliceosome I (E6*I), and high CCDC106 expression in cervical carcinogenesis. We found that E6 was alternatively spliced into the E6*I transcript in HPV‐ CCDC016 integration samples with low p53 expression, in contrast to the role of E6*I in preventing p53 degradation in cervical cancer cells. In addition, CCDC106 was highly expressed after HPV‐ CCDC106 integration, and interacted with p53, resulting in p53 degradation and cervical cancer cell progression in vitro and in vivo. Importantly, when E6*I was highly expressed in cervical cancer cells, overexpression of CCDC106 independently degraded p53 and promoted cervical cancer cell progression. In this study, we explored the underlying mechanisms of HPV‐ CCDC106 integration in HPV carcinogenesis after HPV E6 splicing, which should provide insight into host genome dysregulation in cervical carcinogenesis.